Polymorph screening of an active material | Land Portal

Informações sobre recurso

Date of publication: 
Dezembro 2013
Resource Language: 
ISBN / Resource ID: 
AGRIS:US201500121573
Pages: 
177-183

Polymorph screening is currently one of the most important tasks for innovators and for generic companies from both pharmaceutical and intellectual property rights aspects. The different polymorphs have different physicochemical properties, such as the crystal polymorph-dependent solubility which influences the bioavailability. A former drug candidate obtained from Sanofi Pharmaceutical Company (Hungary) was investigated to explore its polymorphism, to distinguish the morphologies generated by analytical examinations and to investigate their relative stabilities. An Avantium Crystal 16 automatic laboratory reactor system was used for the polymorph studies and the studies of their dissolution. Eight polymorphs were obtained by crystallization and transformation methods then characterized by XRPD, DSC, and Raman spectroscopy, scanning electron microscopy, and light microscopy. All the morphologies could be stored in solid without any form transformation for a long time (2 years investigated). According to the first relative stability results, Form I, III, IVa, V, VI, VII are unambiguously metastable forms. Form II and IVb have similar thermodynamic stabilities, that were higher than those of the other polymorphs. A special dissolution medium was developed in which the eight polymorphs showed clear differences in the rate of dissolution.

Autores e editores

Author(s), editor(s), contributor(s): 

Láng, P.
Kiss, V.
Ambrus, R.
Farkas, G.
Szabó-Révész, P.
Aigner, Z.
Várkonyi, E.

Publisher(s): 

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals.

All knowledge begins as uncommon—unrecognized, undervalued, and sometimes unaccepted. But with the right perspective, the uncommon can become the exceptional.

Provedor de dados

Foco geográfico

Compartilhe esta página